CIK 0001725160 · Non-accelerated filer<br>Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823607803
- Phone
- (858) 263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-02 | Lackner Mark Chief Scientific Officer | Sale | −1,585 | $11.54 | $18K | 195,728 |
| 2024-02-02 | Paul Andrea Chief Legal Officer | Sale | −3,310 | $11.54 | $38K | 149,973 |
| 2024-02-02 | Gallagher Cam President | Sale | −11,552 | $11.54 | $133K | 644,450 |
| 2024-02-02 | Epperly Melissa B, Chief Financial Officer | Sale | −8,669 | $11.54 | $100K | 454,022 |
| 2024-02-01 | HAUSMAN DIANA Chief Medical Officer | Grant or award | +337,500 | 377,232 | ||
| 2024-02-01 | HAUSMAN DIANA Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +337,500 | 337,500 | ||
| 2024-02-01 | Lackner Mark Chief Scientific Officer | Grant or award | +141,000 | 197,313 | ||
| 2024-02-01 | Lackner Mark Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +141,000 | 141,000 | ||
| 2024-02-01 | Paul Andrea Chief Legal Officer | Grant or award | +112,500 | 153,283 | ||
| 2024-02-01 | Paul Andrea Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +112,500 | 112,500 | ||
| 2024-02-01 | Paul Andrea Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2024-02-01 | Gallagher Cam President | Grant or award | +192,500 | 656,002 | ||
| 2024-02-01 | Gallagher Cam President | Grant or award · Stock Option (Right to Buy) | +192,500 | 192,500 | ||
| 2024-02-01 | Epperly Melissa B, Chief Financial Officer | Grant or award | +75,000 | 462,691 | ||
| 2024-02-01 | Epperly Melissa B, Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-02-01 | Blackwell Kimberly Chief Executive Officer | Grant or award | +250,000 | 504,800 | ||
| 2024-02-01 | Blackwell Kimberly Chief Executive Officer | Shares withheld for taxes | −20,655 | $11.69 | $241K | 484,145 |
| 2024-02-01 | Blackwell Kimberly Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2024-01-02 | Lackner Mark Chief Scientific Officer | Grant or award | +40,000 | 56,313 | ||
| 2024-01-02 | Lackner Mark Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 |
Page 4 of 8 · 160 trades